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            The successful treatment of paroxysmal supraventricular tachycardia with adenosine 5` 
triphosphate (ATP) was initially reported by Somlo1 in 1955. Sharma et al2 noted the value of 
intravenous ATP in the diagnosis and management of wide QRS complex tachycardia. ATP in 
incremental doses has been used for the non-invasive diagnosis of concealed accessory 
pathways3.
            Non-invasive diagnosis of dual AV node physiology (DAVNP) in patients with AV 
nodal reentrant tachycardia by administration of ATP or adenosine has been reported by 
different authors4,5. Though many of the studies were using incremental dosage, single dose 
tests with ATP6 and adenosine7 have also been useful in the diagnosis of DAVNP. The test is 
useful in sinus rhythm to establish the presence of DAVNP. DAVNP is considered to be present 
when at least one of the following events occur following ATP injection: 1) PR interval 
increases or decreases by >50 ms in 2 consecutive sinus beats; 2) an AV nodal echo beat is 
observed; 3) AVNRT develops. In this issue of the Journal, Belhassen et al8 report that DAVNP 
is present in a relatively high proportion (36.5%) of patients following termination of AVNRT 
with ATP but is much less frequent (5.5%) in control patients. In addition, they show that the 
occurrence of DAVNP following the administration of ATP in sinus rhythm is a good predictor 
of its occurrence after termination of AVNRT with ATP. Thus, findings at termination of 
tachycardia by ATP may be useful in the noninvasive diagnosis of the mechanism of a 
paroxysmal supraventricular tachycardia.
            In patients with palpitations of unclear etiology, ATP test identifies those who are likely 
to have AVNRT or AVRT (and who are therefore likely to benefit from electrophysiological 
evaluation) with a high positive predictive value9. ATP/adenosine test is also useful in 
confirming the result of radiofrequency ablation of slow pathway6,10. Among patients with no 
history suggestive of AVNRT, less than 3% have clinically silent DAVNP on incremental 
adenosine infusion11. Adenosine/ATP infusion can be used a simple bedside screening test for 
patients with symptoms suggestive of of paroxysmal supraventricular tachycardia which is 
undocumented and in those in whom the mechanism of a narrow complex tachycardia is unclear. 
This test may be specially relevant in developing countries with limited resources, in selecting 
patients for further electrophysiological evaluation.
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